The MedTech Accelerator provides medical device and healthcare IT early stage companies with personalized business development plans to collaborate with Mayo Clinic and ASU and accelerate go to market and investment opportunities.
Access to Investors, Entrepreneurs in Residence (EIRs), Mentors, and Mayo Clinic Physicians
Customer interactions with the health care ecosystem
Research collaborations and clinical studies to validate technologies
MedTech milestones resulting in a Mayo Clinic and ASU completion certificate
Program
The immersive experience will help participants develop or optimize new products and services, license intellectual property and sponsor research/clinical studies through individually tailored development plans, a trusted medtech entrepreneurship curriculum, idea mentoring and customer interactions within the health care ecosystem.
Early-stage medical device and health care IT startups
Growth and late-stage startups considering health care as an adjacent market for new products and services
Companies must be based in the U.S. and have raised at least $500,000 in seed capital and/or are generating recurring revenue.
Each company selected will be required to execute a participation agreement and pay $50,000 (payable as cash or a convertible note) to participate in the program.
Mayo Clinic is the #1 hospital in the U.S., #1 in Arizona, and #1 in more specialities than any other hospital
ASU is the #1 university in the U.S. for innovation for the fourth year in a row, ahead of Stanford and MIT. (U.S. News and World Report)
The total amount of funding raised by Arizona State University-linked startups to almost three-quarters of a billion dollars.
At any given time, more than 8,000 human research studies are underway at Mayo Clinic. ASU is one of the fastest-growing research universities in the country, among those with $100 million+ in annual research expenditures.
Mayo Clinic’s intellectual property provides competitive advantages for over 100 technology startups.
ASU is a university on the forefront of biomedical ingenuity and is ranked in the top 1 percent of the world's most prestigious universities (Times Higher Education).
